| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $7.3M | +1181.3% |
| R&D Expense | $25.6M | -30.4% |
| SG&A Expense | $24.1M | -6.1% |
| Operating Income | -$42.4M | +31.4% |
| Pre-tax Income | -$17.4M | +34.1% |
| Income Tax | $0 | — |
| Net Income | -$17.4M | +34.1% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $13.2M | -50.0% |
| Current Assets | $74.4M | +32.9% |
| Total Assets | $150.9M | +63.8% |
| Current Liabilities | $8.3M | -21.2% |
| Total Liabilities | $20.3M | -15.3% |
| Stockholders' Equity | $130.7M | +91.5% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$38.3M | +31.5% |
| Capital Expenditures | $0 | -100.0% |
| Investing Cash Flow | -$49.9M | -191.3% |
| Financing Cash Flow | $75.2M | — |
| Free Cash Flow | -$38.3M | +31.6% |